01.03.2018 • NewsAvevaSchneider Electric

AVEVA Completes Transformational Combination

From industrial commodities to pharmaceuticals, Aveva technology helps to...
From industrial commodities to pharmaceuticals, Aveva technology helps to effectively design and operate chemical plants.

Aveva, a global leader in engineering and industrial software, has combined with Schneider Electric’s industrial software business to drive digital transformation across the asset and operational life cycle for capital-intensive industries. According to the Cambridge, UK-based group this end-to-end offering unlocks the power of two industry leaders to deliver improved profitability and operational excellence to maximize return on capital.

The combination brings together Aveva’s design, engineering and construction capabilities with Schneider Electric’s industrial software business, which ranges from simulation through to real-time manufacturing operations management. It creates a global leader in engineering and industrial software, expanding the markets and industries the company serves. Customers can benefit from   improved profitability, efficiency and performance.

Industries served include chemical; food and beverage; infrastructure and smart cities; life sciences; mining, minerals and metals; oil and gas (upstream, mid-stream and downstream); power and utilities; shipbuilding; water and wastewater.

“88% of leaders in capital-intensive industries say that digitalization would increase their revenues”, said Craig Hayman, CEO at Aveva. “Yet less than half of these companies are actually in the process of adopting a digital strategy. This represents an incredible opportunity for Aveva to be our customer’s digital transformation partner.”

“Digitalization demands a fundamental rethink of the way organizations operate. They need to be confident that their technology investment will deliver a high return on capital and can lower the total cost of asset ownership. Aveva’s combination of proven solutions, industry-specific knowledge and a global partner ecosystem will drive innovation across capital-intensive industries, as companies plan their digital transformation journey,” Hayman added.

Aveva has over 4,400 people across 80 locations in over 40 countries. Its global headquarters is in Cambridge, UK.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.